Age and prognosis of papillary thyroid carcinoma = retrospective stratification into three groups

다국어 초록 (Multilingual Abstract)

We investigated the prognosis according to age in papillary thyroid carcinoma (PTC) patients. Methods: We retrospectively evaluated 2,890 patients who underwent thyroidectomy due to PTC between May 2004 and Aug 2008. We divided patients into 3 groups: young (≤35 years old), middle (between 35 and 54 years old), and old (≥55 years old). Results: Median age was 47.0 years old (range, 15 to 82 years). Within a follow-up period median of 50 months, there were 148 (5.1%) locoregional recurrences, 6 (0.2%) PTC-related deaths, and 18 (0.6%) PTC-unrelated deaths. Outcomes were more favorable in the young group, with no PTC-related death despite the frequent locoregional recurrence. In the old group compared to the middle, there was a higher proportion of male, and more aggressive types as T3 or N1b, higher mean tumor number, more multiplicity, and bilaterality. The old group of ≥55 years did not show a significant difference in PTC-related deaths than other age groups in Cox analysis (OR, 0.9; P = 0.677), but a significant cutoff age in PTC-related deaths at 62.5 years was determined in ROC analysis (area under curve = 0.912). Conclusion: We showed that the ≤35 years group shows favorable prognosis despite the frequent locoregional recurrence and ≥62.5 years group shows a poor prognosis regardless of other factors such as male sex or tumor aggressiveness. Further multiinstitutional studies are needed to elucidate the prognosis according to patient’s age.

목차 (Table of Contents)

• Abstract
• INTRODUCTION
• METHODS
• RESULTS
• DISCUSSION
• CONFLICTS OF INTEREST
• REFERENCES

참고문헌 (Reference)

1 Fassina AS, "Thyroid cancer in children and adolescents" 80 : 257-262, 1994

2 Ceccarelli C, "Thyroid cancer in children and adolescents" 104 : 1143-1148, 1988

3 Sobin LH, "TNM classification of malignant tumours. 7th ed" Wiley- Blackwell 2010

4 Segal K, "Surgery of thyroid cancer in children and adolescents" 20 : 293-297, 1998

5 Ito Y, "Relationship between prognosis of papillary thyroid carcinoma patient and age: a retrospective single-institution study" 59 : 399-405, 2012

6 Akslen LA, "Prognostic importance of histologic grading in papillary thyroid carcinoma" 72 : 2680-2685, 1993

7 Hay ID, "Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989" 114 : 1050-1057, 1993

8 Palmer BA, "Papillary thyroid carcinoma in children: risk factors and complications of disease recurrence" 40 : 1284-1288, 2005

9 Miccoli P, "Papillary thyroid cancer: pathological parameters as prognostic factors in different classes of age" 138 : 200-203, 2008

10 DeGroot LJ, "Natural history, treatment, and course of papillary thyroid carcinoma" 71 : 414-424, 1990

11 Yamashita S, "Mechanisms of disease: molecular genetics of childhood thyroid cancers" 3 : 422-429, 2007

12 Cooper DS, "Management guidelines for patients with thyroid nodules and differentiated thyroid cancer" 16 : 109-142, 2006

13 Hay ID, "Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008" 34 : 1192-1202, 2010

14 Mazzaferri EL, "Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer" 97 : 418-428, 1994

15 Kim WW, "Is robotic surgery superior to endoscopic and open surgeries in thyroid cancer?" 35 : 779-784, 2011

16 Ito Y, "Establishment of an intraoperative staging system (iStage) by improving UICC TNM classification system for papillary thyroid carcinoma" 34 : 2570-2580, 2010

17 Papendieck P, "Differentiated thyroid carcinoma: presentation and follow-up in children and adolescents" 24 : 743-748, 2011

18 Hod N, "Differentiated thyroid carcinoma in children and young adults: evaluation of response to treatment" 30 : 387-390, 2005

19 Dottorini ME, "Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients" 38 : 669-675, 1997

20 Mazzaferri EL, "Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer" 86 : 1447-1463, 2001

21 Vriens MR, "Clinical and molecular features of papillary thyroid cancer in adolescents and young adults" 117 : 259-267, 2011

22 Greene FL, "Cancer staging, prognostic factors, and our surgical challenges" 71 : 615-620, 2005

23 Penko K, "BRAF mutations are uncommon in papillary thyroid cancer of young patients" 15 : 320-325, 2005

24 Lima J, "BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas" 89 : 4267-4271, 2004

25 Ito Y, "An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid" 13 : 381-387, 2003

26 Cady B, "An expanded view of risk-group definition in differentiated thyroid carcinoma" 104 : 947-953, 1988

27 Byar DP, "A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group" 15 : 1033-1041, 1979

28 Sugitani I, "A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period" 135 : 139-148, 2004

29 남기현, "75세 이상 고령 갑상선암 환자의 임상 양상과 치료 성적" 대한외과학회 69 (69): 7-12, 2005

30 남기현, "20세 이하 분화 갑상선암: 임상병리적 특징과 예후인자" 대한외과학회 69 (69): 443-449, 2005